Loading...

PAI-1 in Diabetes: Pathophysiology and Role as a Therapeutic Target

Hypofibrinolysis is a key abnormality in diabetes and contributes to the adverse vascular outcome in this population. Plasminogen activator inhibitor (PAI)-1 is an important regulator of the fibrinolytic process and levels of this antifibrinolytic protein are elevated in diabetes and insulin resista...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Int J Mol Sci
Main Authors: Altalhi, Rawan, Pechlivani, Nikoletta, Ajjan, Ramzi A.
Format: Artigo
Sprog:Inglês
Udgivet: MDPI 2021
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8003717/
https://ncbi.nlm.nih.gov/pubmed/33804680
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22063170
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!